Indication
Quadriplegia
2 clinical trials
2 products
Clinical trial
A Pilot Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)Status: Recruiting, Estimated PCD: 2025-05-01
Product
Ursolic AcidClinical trial
Enabling Forelimb Function With Agonist Drug and Epidural Stimulation in SCIStatus: Active (not recruiting), Estimated PCD: 2024-12-30
Product
Buspirone